Please login to the form below

Not currently logged in
Email:
Password:

EPO

This page shows the latest EPO news and features for those working in and with pharma, biotech and healthcare.

UK Supreme Court rules in favour of Servier in NHS patent lawsuit

UK Supreme Court rules in favour of Servier in NHS patent lawsuit

The patent was then revoked in 2009. The NHS initially sued Servier in 2001, accusing Servier of deceiving the European Patent Office (EPO) in order to uphold the patent, causing financial

Latest news

More from news
Approximately 1 fully matching, plus 30 partially matching documents found.

Latest Intelligence

  • Piloting a route to the biosimilars opportunities in Europe Piloting a route to the biosimilars opportunities in Europe

    After the introduction of biosimilars in Portugal for erythropoietin (EPO), a hormone produced by the kidneys to stimulate production and maintenance of crucial red blood cells, the originator product was reduced

  • 2016: The year when deal-makers took stock? 2016: The year when deal-makers took stock?

    product. (According to the journal Biosimilar Development the price of EPO in Norway was sold at an 83% discount from the original price.).

  • Can biosimilars live up to the hype? Can biosimilars live up to the hype?

    For instance, in Germany, an estimated 0.5bn has been saved with the introduction of Epo biosimilars and there has been a dramatic expansion in the use of the biosimilar filgrastim

  • Deal Watch February 2016 Deal Watch February 2016

    licence. 105. †† Genexine/ Shanghai Chemo WanBang Biopharma. GX-E2 (EPO-hyFc), a novel Fc-engineered (hyFc) long acting EPO, for anaemia due to chronic kidney disease and chemotherapy.

  • An eye towards the biobetter in South Korea An eye towards the biobetter in South Korea

    EPO-Fc. EPO-hybrid Fc. Anaemia. S Korea. Phase I. Hanferon (HL143). HanAll Biopharma. ... Hormone deficiency. S Korea. Phase I Completed Dec 2011. HL033. Improved EPO.

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
ROAD

ROAD is a digital PR and communications consultancy specialising in promoting the innovators that shape our future health and wellbeing....

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...